UK investor profile and portfolio
Sofinnova Partners
4 UK company relationship(s) retained from funding evidence.
2 as lead
UK portfolio companies
- Crescendo BiologicsEast of England
- Mission TherapeuticsEast of England
- Purespring TherapeuticsLondon
- Sitryx TherapeuticsSouth East
Sources
- https://www.cambridgeindependent.co.uk/business/crescendo-biologics-32m-for-humabody-therapeutics-go-ahead-9323185/
- https://www.finsmes.com/2024/03/mission-therapeutics-raises-25-2m-in-funding.html
- https://sofinnovapartners.com/news/mission-therapeutics-raises-gbp25-2-million-to-progress-clinical-candidates-in-the-area-of-mitophagy
- https://www.globenewswire.com/news-release/2024/10/09/2960230/0/en/Purespring-Therapeutics-raises-80-105-million-in-a-Series-B-financing-to-transform-the-treatment-of-kidney-diseases.html
- https://www.fiercebiotech.com/biotech/purespring-bottles-105m-series-b-bring-kidney-disease-gene-therapy-clinic
- https://svhealthinvestors.com/news/sitryx-raises-additional-39-million-to-progress-development-of-disease-modifying-therapeutics-for-chronic-autoimmune-and-inflammatory-diseases
- https://www.globenewswire.com/news-release/2023/09/27/2750055/0/en/Sitryx-raises-additional-39-million-to-progress-development-of-disease-modifying-therapeutics-for-chronic-autoimmune-and-inflammatory-disease.html